Phoenix Pharmaceuticals, Inc. synthesizes chimeric peptides derived from GLP-1, GIP, and Glucagon

Schematics

Foods eating increase insulin level & proGIP and proglucagon. During fasting both GLP-1 and insulin secretion decrease. Conversely, glucagon secretion increases, further maintaining insulin secretion. The stimulated amino acids uptake and glucose production using alternative sources of energy, helping maintain normoglycemia and normal body weight. Increased intake of carbohydrates stimulates GLP-1 secretion and insulin secretion, both GLP-1 and insulin decrease glucagon secretion. In this scenario increased insulin level promote glucose uptake and storage, leading to weight gain and maintaining normal blood sugar levels.

 

GEP44 (Cat. # 028-97), GEP12 (Cat. # 028-98) are made according the reference and Figure from: 

Sci Rep. 2023 Jun 12;13(1):9554. doi: 10.1038/s41598-023-36178-1

Related Products

Catalog
Product
Size
Price
Buy Now